{
  "paper_metadata": {
    "pmid": "33357097",
    "title": "MAIN TEXT",
    "extraction_summary": "The paper discusses the BRCA2 N372 H i.a.1342A>C variant and its role in platinum resistance in ovarian cancer, providing functional data and some penetrance information."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.1342A>C",
      "protein_notation": "p.Asn372His",
      "genomic_position": "rs144848",
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 1,
        "demographics": "not specified",
        "phenotype": "platinum-resistant ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "platinum-resistant ovarian cancer",
          "evidence_sentence": "This study aimed to further investigate the mechanism of BRCA2 N372 H mutation in the development of platinum resistance in ovarian cancer."
        }
      ],
      "functional_data": {
        "summary": "The BRCA2 N372 H i.a.1342A>C variant was synthesized and shown to increase BRCA2 protein expression and RAD51 binding, leading to increased cell viability and resistance to cisplatin.",
        "assays": [
          "qPCR for BRCA2 mRNA expression",
          "Immunoblotting for BRCA2 protein levels",
          "Immunofluorescence for RAD51 binding",
          "CCK-8 assay for cell viability"
        ]
      },
      "segregation_data": "The variant was specifically found in platinum-resistant patients.",
      "population_frequency": "not specified",
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The study suggests a potential mechanism for platinum resistance in ovarian cancer linked to this variant.",
      "key_quotes": [
        "BRCA2 N372 H i.a.1342A>C heterozygous variation presented in platinum-resistant patients.",
        "Over expression of mRNA and protein of BRCA2 was detected in the cells with BRCA2 N372 H i.a.1342A>C mutation."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "The extraction was straightforward as the paper focused on a single variant in BRCA2."
  }
}